Tetrazole

Tetrazole

SCHEMBL3922918

O=P(O)(O)Oc1cc2c(Cl)c(Br)ccc2[nH]1.c1nnn[nH]1.c1nnn[nH]1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrazole SCHEMBL5041698 1.00
Tetrazole SCHEMBL5041695 1.00
Tetrazole SCHEMBL6400674 0.99
SCHEMBL79536 0.88 DAO (0.33)
Tetrazole SCHEMBL1613289 0.86
SCHEMBL79535 0.77 DAO (0.32)
SCHEMBL6140846 0.77 ALDH1A1 (0.33)
SCHEMBL5330341 0.77 ALDH1A1 (0.33)
Phosphoric Acid SCHEMBL27603366 0.76 P2RX7 (0.34)
Tetrazole SCHEMBL225087 0.76 HTR2A (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005054800-A1 FREEZE THAW INDICATOR CHROMA CHEM PTY LTD (AU) 2005-06-16 WO claimed
EP-1009404-A4 METHODS FOR TREATING INFLAMMATION AND INFLAMMATORY DISEASES USING pADPRT INHIBITORS OCTAMER INC (US) 2009-07-01 EP disclosed
US-20080268477-A1 Antibody Reactive Specifically to Age Derived from 3,4-Dge JMS CO., LTD. (JP) 2008-10-30 US disclosed
US-6344552-B1 A RECOMBINANT DNA ENCODING AN OUTER SURFACE POLYPEPTIDE A; THERAPY AND DIAGNOSIS OF LYME DISEASE IN HUMANS AND ANIMALS YALE UNIVERSITY 2002-02-05 US disclosed
US-6303629-B1 TREATING ARTHRITIS IN AN ANIMAL OR MAMMAL BY ADMINISTERING TO AN ANIMAL OR MAMMAL A INHIBITOR OF NUCLEAR ENZYME POLY-ADP RIBOSE POLYMERASE (PADPRT) OCTAMER, INC. 2001-10-16 US disclosed
US-6197301-B1 Compositions and methods for the prevention and diagnosis of Lyme disease YALE UNIVERSITY 2001-03-06 US disclosed
EP-1009404-A1 METHODS FOR TREATING INFLAMMATION AND INFLAMMATORY DISEASES USING pADPRT INHIBITORS Octamer, Inc. (US) 2000-06-21 EP disclosed
US-5908861-A Methods for treating inflammation and inflammatory disease using pADPRT inhibitors OCTAMER, INC. (US) 1999-06-01 US disclosed
WO-1998051308-A1 METHODS FOR TREATING INFLAMMATION AND INFLAMMATORY DISEASES USING pADPRT INHIBITORS OCTAMER, INC. (US) 1998-11-19 WO disclosed
WO-1998051307-A1 METHODS FOR TREATING INFLAMMATION, INFLAMMATORY DISEASES, ARTHRITIS AND STROKE USING pADPRT INHIBITORS OCTAMER, INC. (US) 1998-11-19 WO disclosed
EP-0578817-A4 A DNA SEQUENCE AND ENCODED POLYPEPTIDE USEFUL IN THE DIAGNOSIS OF HEPATITIS DISEASE BAXTER DIAGNOSTICS INC (US) 1995-11-29 EP disclosed
US-5437974-A 20E, a cDNA clone DADE INTERNATIONAL INC (US) 1995-08-01 US disclosed
EP-0578817-A1 A DNA SEQUENCE AND ENCODED POLYPEPTIDE USEFUL IN THE DIAGNOSIS OF HEPATITIS DISEASE DADE INTERNATIONAL INC. (US) 1994-01-19 EP disclosed
WO-1993015111-A1 A DNA SEQUENCE AND ENCODED POLYPEPTIDE USEFUL IN THE DIAGNOSIS OF HEPATITIS DISEASE BAXTER DIAGNOSTICS INC. (US) 1993-08-05 WO disclosed
EP-0536335-A4 COMPOSITIONS AND METHODS FOR THE PREVENTION AND DIAGNOSIS OF LYME DISEASE 1993-07-14 EP disclosed
EP-0536335-A1 COMPOSITIONS AND METHODS FOR THE PREVENTION AND DIAGNOSIS OF LYME DISEASE YALE UNIVERSITY (US) 1993-04-14 EP disclosed
EP-0252641-B1 DIAGNOSIS OF LYME DISEASE BioWhittaker, Inc. (US) 1992-09-09 EP disclosed
WO-1992000055-A1 COMPOSITIONS AND METHODS FOR THE PREVENTION AND DIAGNOSIS OF LYME DISEASE YALE UNIVERSITY (US) 1992-01-09 WO disclosed
US-4888276-A DETECTING ANTIGENS OF CAUSATIVE BACTERIUM IN URINE SAMPLE BY COMPLEXING WITH ANTIBODY MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-12-19 US disclosed
EP-0252641-A1 Diagnosis of lyme disease BioWhittaker, Inc. (US) 1988-01-13 EP disclosed